Opko Health Inc. (NASDAQ:OPK) CEO Phillip Md Et Al Frost acquired 30,000 shares of the stock in a transaction dated Thursday, April 11th. The stock was bought at an average price of $2.49 per share, for a total transaction of $74,700.00. Following the purchase, the chief executive officer now owns 3,068,951 shares of the company’s stock, valued at approximately $7,641,687.99. The transaction was disclosed in a legal filing with the SEC, which is accessible through this hyperlink.

Phillip Md Et Al Frost also recently made the following trade(s):

  • On Tuesday, April 9th, Phillip Md Et Al Frost acquired 10,000 shares of Opko Health stock. The stock was bought at an average price of $2.51 per share, for a total transaction of $25,100.00.
  • On Thursday, April 4th, Phillip Md Et Al Frost purchased 20,000 shares of Opko Health stock. The shares were acquired at an average price of $2.53 per share, for a total transaction of $50,600.00.
  • On Monday, April 1st, Phillip Md Et Al Frost purchased 20,000 shares of Opko Health stock. The shares were acquired at an average price of $2.58 per share, for a total transaction of $51,600.00.
  • On Wednesday, March 27th, Phillip Md Et Al Frost purchased 100,000 shares of Opko Health stock. The shares were acquired at an average price of $2.49 per share, for a total transaction of $249,000.00.
  • On Monday, March 18th, Phillip Md Et Al Frost purchased 40,000 shares of Opko Health stock. The shares were acquired at an average price of $2.47 per share, for a total transaction of $98,800.00.
  • On Thursday, March 14th, Phillip Md Et Al Frost purchased 250,000 shares of Opko Health stock. The shares were acquired at an average price of $2.45 per share, for a total transaction of $612,500.00.
  • On Wednesday, March 6th, Phillip Md Et Al Frost purchased 50,000 shares of Opko Health stock. The shares were acquired at an average price of $2.57 per share, for a total transaction of $128,500.00.
  • On Thursday, February 28th, Phillip Md Et Al Frost purchased 200,000 shares of Opko Health stock. The shares were acquired at an average price of $2.48 per share, for a total transaction of $496,000.00.
  • On Wednesday, January 16th, Phillip Md Et Al Frost purchased 10,000 shares of Opko Health stock. The shares were acquired at an average price of $3.74 per share, for a total transaction of $37,400.00.
  • On Monday, January 14th, Phillip Md Et Al Frost purchased 15,000 shares of Opko Health stock. The shares were acquired at an average price of $3.74 per share, for a total transaction of $56,100.00.

Shares of NASDAQ OPK opened at $2.48 on Monday. The firm has a market cap of $1.50 billion, a price-to-earnings ratio of -9.92 and a beta of 1.88. Opko Health Inc. has a 52-week low of $2.34 and a 52-week high of $6.40. The company has a debt-to-equity ratio of 0.03, a current ratio of 1.10 and a quick ratio of 0.96.

Opko Health (NASDAQ:OPK) last issued its quarterly earnings data on Wednesday, February 27th. The biotechnology company reported ($0.08) earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of ($0.09) by $0.01. Opko Health had a negative return on equity of 7.69% and a negative net margin of 15.46%. The company had revenue of $221.90 million during the quarter, compared to analysts’ expectations of $242.05 million. As a group, sell-side analysts predict that Opko Health Inc. will post -0.2 earnings per share for the current year.

Several institutional investors have recently added to or reduced their stakes in the stock. D. E. Shaw & Co. Inc. raised its holdings in shares of Opko Health by 20.5% in the fourth quarter. D. E. Shaw & Co. Inc. now owns 24,165 shares of the biotechnology company’s stock valued at $73,000 after buying an additional 4,104 shares during the last quarter. Zurcher Kantonalbank Zurich Cantonalbank raised its holdings in shares of Opko Health by 36.0% in the fourth quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 23,049 shares of the biotechnology company’s stock valued at $69,000 after buying an additional 6,097 shares during the last quarter. Legal & General Group Plc raised its holdings in shares of Opko Health by 5.8% in the fourth quarter. Legal & General Group Plc now owns 119,829 shares of the biotechnology company’s stock valued at $361,000 after buying an additional 6,540 shares during the last quarter. Diversified Trust Co bought a new position in shares of Opko Health in the fourth quarter valued at about $30,000. Finally, FDx Advisors Inc. bought a new position in shares of Opko Health in the fourth quarter valued at about $33,000. 23.10% of the stock is owned by institutional investors and hedge funds.

OPK has been the topic of a number of recent research reports. ValuEngine upgraded shares of Opko Health from a “sell” rating to a “hold” rating in a research note on Wednesday, January 2nd. Zacks Investment Research downgraded shares of Opko Health from a “buy” rating to a “hold” rating in a research note on Monday, February 4th. Finally, Barrington Research reiterated a “buy” rating and set a $5.00 price target on shares of Opko Health in a research note on Thursday, February 28th. Two investment analysts have rated the stock with a hold rating and three have issued a buy rating to the stock. The company has an average rating of “Buy” and an average price target of $9.67.

ILLEGAL ACTIVITY WARNING: This news story was first reported by Daily Political and is owned by of Daily Political. If you are reading this news story on another site, it was illegally stolen and reposted in violation of US and international trademark & copyright law. The correct version of this news story can be accessed at https://www.dailypolitical.com/2019/04/15/insider-buying-opko-health-inc-opk-ceo-buys-74700-00-in-stock.html.

About Opko Health

OPKO Health, Inc, a healthcare company, engages in the diagnostics and pharmaceuticals business in the United States, Ireland, Chile, Spain, Israel, Mexico, and internationally. The company's Diagnostics segment operates BioReference Laboratories, a clinical laboratory that offers laboratory testing services.

Further Reading: Average Daily Trade Volume – ADTV

Insider Buying and Selling by Quarter for Opko Health (NASDAQ:OPK)

Receive News & Ratings for Opko Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Opko Health and related companies with MarketBeat.com's FREE daily email newsletter.